Treatment of rickets and dyslipidemia in twins with progressive familial intrahepatic cholestasis type 2.

Published in: International journal of pediatric endocrinology (2020)

Higher doses of Vitamin D therapy are needed for treatment of rickets secondary to cholestasis. Extremely low HDL-C levels are characteristic of PFIC and improve with treatment of underlying cholestasis. Maternal intrahepatic cholestasis during pregnancy can be an early warning sign.

Keyphrases

stem cells
drug induced
multiple sclerosis
pregnant women
body mass index
mesenchymal stem cells
early onset
physical activity
combination therapy
smoking cessation
gestational age